Skip to main content

Table 6 Comparison of mean scores for the QLQ-C30 and QLQ-BLM30 between patients with stage II and stage III bladder cancer and with high and low physical function at baseline (T6wk)

From: Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer

 

Total

Stage II (n = 430)

Stage III (n = 220)

Effect sizec

PF > =90 (n = 228)

PF < 90 (n = 422)

Effect sizec

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

QLQ-C30

 Global health status / QoLa

69.4

19.5

70.6

18.9

66.9

20.3

0.19

81.1

14.1

62.9

19.0

0.93

Functioning scalesa

 Physical function

76.6

22.6

76.1

23.1

77.5

21.6

−0.06

97.2

3.3

65.3

20.6

1.41

 Role function

72.2

29.2

73.0

29.0

70.8

29.5

0.08

90.6

17.8

62.2

29.3

0.97

 Emotional function

79.9

19.9

80.5

20.3

78.8

19.1

0.08

85.3

14.5

77.0

21.7

0.42

 Cognitive function

86.6

18.7

86.9

17.9

85.8

20.1

0.06

94.0

10.8

82.5

20.7

0.62

 Social function

81.5

23.5

81.6

23.7

81.3

23.0

0.01

91.7

15.1

75.8

25.3

0.68

Symptom scalesb

 Fatigue

32.0

25.3

31.3

24.3

33.3

27.1

−0.08

16.3

18.7

40.6

24.3

−0.96

 Nausea and vomiting

6.2

14.8

5.8

13.9

7.2

16.4

−0.09

2.6

8.3

8.3

17.1

−0.38

 Pain

20.4

24.2

18.6

22.5

23.9

26.9

−0.22

8.7

15.8

26.8

25.6

−0.75

QLQ-BLM30

Scales

  Urinary symptomb

34.1

22.7

32.5

21.9

37.5

23.9

−0.04

28.7

21.6

37.6

22.7

−0.39

  Urostomy problemb

28.3

21.4

27.9

22.3

28.8

20.3

−0.11

18.9

14.9

29.5

21.8

−0.50

  Future perspectiveb

43.4

25.9

42.4

25.2

45.4

27.2

−0.05

40.1

23.6

45.3

27.0

−0.20

  Abdominal bloating and flatulenceb

17.4

20.2

17.1

20.4

18.0

19.7

−0.08

11.9

16.5

20.4

21.3

−0.42

  Body imageb

13.9

19.8

13.3

18.9

14.9

21.5

0.04

7.5

14.7

17.3

21.4

−0.49

  Sexual functioninga

14.9

19.8

15.2

20.2

14.4

19.0

0.10

23.3

21.0

10.0

17.2

0.68

  Male sexual problemsb

34.5

37.4

35.8

38.3

31.9

35.5

0.05

25.7

29.1

41.2

41.5

−0.41

Single items

  Single cathether use problem

32.5

37.8

33.3

38.7

31.4

37.0

0.05

11.8

20.2

37.7

39.4

−0.69

  Urostomy irritationb

23.5

25.8

20.3

25.9

27.9

25.5

−0.30

20.0

23.3

23.9

26.3

−0.15

  Urostomy embarrassmentb

24.1

32.0

24.7

33.5

23.4

30.3

0.04

13.3

17.2

25.5

33.3

−0.38

  Urostomy supportb

55.3

34.2

55.6

35.1

55.0

33.5

0.02

40.0

30.6

57.3

34.4

−0.50

  Sexual intimacyb

15.9

26.7

15.6

26.6

16.4

27.0

−0.03

12.9

23.5

18.3

28.8

−0.20

  Risk of contaminating partnerb

16.0

28.3

14.7

27.4

18.6

30.0

−0.14

13.9

26.6

17.9

29.7

−0.14

  Sexual enjoymenta

29.6

34.3

28.3

33.3

32.4

36.1

−0.12

40.0

34.4

20.9

31.7

0.56

  Female sexual problemsb

20.7

28.7

20.5

28.4

21.1

29.8

−0.02

20.7

28.7

8.3

15.1

−0.59

  1. PF Physical functioning, SD Standard Deviation, QoL Quality of Life
  2. a A higher score on this scale indicates better functioning
  3. b A higher score on this scale indicates more symptoms, problems or worries
  4. c Effect size is mean difference divided by the standard deviation of the total population